angiograms is by intraoperative lymphangiography: patent blue is insertedinto the pharyngeal wall at intubation, and the jugular lymph trunks revealed are then cannulated at the time of e.g. laryngectomy; 6 ml Lipiodol Ultra injected over 10 minutes may become standard. Time will be needed to correlate lymphadenogram changes with the fine anatomical studies described above. The difficulties facing the programme include the fact that, since the duration of occult invasion is brief, fortnightly X-ray studies may be needed. Moreover, in many areas lymphadenograms are difficult to obtain after radiotherapy, despite the observations of Burge (1975) on the persistence of perfusion via the lymph system following radiotherapy. It may, however, be possible to limit such intensive radiological survey to a brief period.
The findings to date have been: (1) The slope of the metastatic tree is steep in head and neck cancer, in contrast to some other cancers that metastasize via lymph nodes, e.g. breast cancer.
(2) The original metastases are segmental. (3) There are some long-range fast pathways far back in the neck node system which are invaded especially by post-cricoid and tongue cancers. (4) Separated groups of involved nodes are of bad prognostic significance, since tumour may have left the block and re-entered it, or may have entered by different portals; or may have used rapid long pathways. (5) Tumour spends very little time in the 'occult' state; it is explosive to about 3 cm.
Regarding the neck lymph node system as an organ, a single entity, or at least as a population of neighbours, seems to afford some advantages over the conventional view of it as an isolated collection of micro-fragments of immunological importance, invaded occasionally from afar, and for no obvious good reason, by cancer which uses it as a highway. 
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Management of Metastases to the Lymph Glands of the Neck
The operation of radical neck dissection was first described by Crile in 1906 . The technique remains virtually as he described it, but there is still much to be done in clarifying the indications for this operation. This article, based on a personal series of approximately 2000 patients with head and neck cancer, will pose some questions relating to the management of patients with a squamous carcinoma of the head and neck, with no palpable metastases to the neck, with metastases palpable on only one side of the neck, on both sides of the neck and with fixed metastatic glands.
No Palpable Lymph Gland in the Neck (No) Some enthusiasts still advocate forcefully the policy of prophylactic neck dissection, that is the performance of a radical neck dissection in the *absence of a palpable node, in the hope that some impalpable glands, which are histologically involved by tumour ('occult nodes') will be removed by the operation (Bocca 1976 ). There are two major objections to this policy: (1) There is no evidence that surgery is the correct form of treatment for the patient without a palpable gland. For the vast majority of such patients, whatever the site of the primary tumour, the results of radiotherapy are as good as those of surgery. Radiotherapy is therefore the treatment of choice for such patients in countries with a well developed radiotherapy service, so that prophylactic neck dissection is not a practical issue. (2) No evidence has been produced from prospective randomized trials that prophylactic neck dissection increases the survival rate. In the five years 1965-69 the first author pursued a more aggressive surgical policy than in the five years 1970-74, and a group of patients were submitted to primary surgery and prophylactic neck dissection for a variety of carcinomas of the head and neck. During 1969, the policy of prophylactic neck dissection was abandoned. It is thus possible to draw pairs of patients matched for age. (within ten years), sex, site of tumour and treatment from these groups (i.e. before and after 1969). The details of these pairs are shown in Table 1 .
Twelve of the fifteen pairs are available for follow up at five years, whereas the other three pairs have not yet reached this time interval. The results are shown in Table 2 , which shows that the five-year survival for patients submitted to prophylactic neck dissection was less than that of the 'wait and see' group, but the difference was not statistically significant.
The median survival for both groups is shown in Table 3 ; a Wilcoxon two-sample rank-sum Table 2 Five-year survival Prophylactic 'Wait and see' neck dissection Alive 6 2 Dead 6 10 XI = 3.00, not significant Table 3 Median survival Median survival Prophylactic neck dissection 31.9 months 'Wait and see' 39.5 months r=256.0, not significant test shows that the survival of both groups was not statistically different, although it is freely admitted that there are dangers in drawing conclusions from a retrospective analysis of nonrandomized pairs of patients not treated concurrently.
Perhaps the clearest conclusion from these data is that it is very difficult to find matched pairs of patients with carcinomas of the head and neck, since the fifteen pairs of patients were the only ones who could be matched exactly from a total of almost 2000 patients seen personally in a ten-year period. It will be difficult, therefore, to design a prospective randomized trial. Certainly there is no evidence in the author's experience to support the contention that prophylactic neck dissection. increases the survival rate, and the verdict must remain 'not proven'. A Palpable Gland in One Side ofthe Neck (N1) Most surgeons would agree that surgery should be the treatment of choice for such patients. This is particularly true at two sites: the epiglottis and the tonsil. Surgical developments over the last few years produce results at these two areas which are functionally and cosmetically acceptable: a patient with an epiglottic tumour and a gland in one side of the neck will do very well with a supraglottic laryngectomy and radical neck dissection and has an approximate chance of 60% of five-year survival. This is about twice the survival rate for treatment by radiotherapy.
The five-year survival rate for patients treated purely by radiotherapy for a tonsillar tumour with a gland in the neck is less than 10% (Lederman 1967) ; the survival rate can be increased to a reasonable figure by surgery, which if combined with reconstruction with the deltopectoral flap, as described by Bakamjian (1971) , produces a satisfactory cosmetic and functional result.
Patients who have tumours of the antrum with a gland in the neck should probably not be submitted to surgery. It is doubtful if the antrum has an external lymphatic drainage, so that the appearance of a gland indicates spread beyond the confines of the antrum to rich lymphatic areas. In the first author's experience 5 % of patients with antral carcinoma have a gland in the neck, and their median survival is four months. Although an occasional patient may survive, it is doubtful whether major surgery, for example total maxillectomy, clearance of the orbit and radical neck dissection, is justifiable in the presence of such long odds.
Bilateral Neck Glands (N2) Spread to glands on both sides of the neck is very ominous, with one exception: the patient with a supraglottic tumour. McKelvie (1976) has shown that such tumours spread by emboli to the nearest adjacent node, where they remain localized for long periods and make surgery worthwhile. If the primary tumour is at any other site, bilateral neck glands indicate widespread permeation of the Iymphatics of the neck by carcinoma to areas which are not removed by radical neck dissection. This presumably explains the fact, in the first author's experience, that surgery does not produce a reasonable improvement in survival for patients with bilateral neck glands (Table 4 ). Whilst surgery apparently lengthens the median survival by four months, the price of these four months must be borne in mind: a major mutilating operation and a period of weeks or months in hospital. Such a price for such a small net gain is almost certainly not justified. Fixed Glands in the Neck (N3) Surprisingly, surgery does prolong the survival of patients with fixed glands in the neck (Table 5 ). Furthermore, surgery occasionally cures a patient with a fixed node in the neck (12% at five years).
In carefully selected cases, therefore, surgery may be advised for glands fixed to the mandible or invading the skin. Glands invading the external carotid artery can be treated successfully with surgery by resection of this artery, preserving the common and internal carotid arteries, but it is doubtful whether resection and replacement of the internal or common carotid arteries is justifiable. Fixation to the brachial plexus and the cervical spine must remain as contraindications to surgery.
Summary
The survival rate of matched pairs of patients, one patient in each pair being submitted to prophylactic neck dissection, the other to a policy of 'wait and see' has been measured: there was no significant difference in the survival rates of the two groups.
Surgery for most patients with a gland in the neck gives better results than radiotherapy, and can produce satisfactory results with such procedures as supraglottic laryngectomy for epiglottic tumours and replacement with the deltopectoral flap for tonsillar tumours. On the other hand, surgery is prQbably contraindicated for patients with antral carcinoma and a gland in the neck, whom it rarely cures.
Surgery does not increase the survival of patients with bilateral glands in the neck (except those with supraglottic tumours) and is contraindicated.
Surgery can prolong the survival of patients with nodes fixed to the skin, the mandible or the external carotid artery, and may occasionally cure such patients.
